Skip to content
  • Sunday, 26 July 2026
  • 2:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • MEDVi Under Scrutiny Following FDA Warning, Deceptive AI Advertising, and Multiple Lawsuits
Laboratory Automation & Robotics

MEDVi Under Scrutiny Following FDA Warning, Deceptive AI Advertising, and Multiple Lawsuits

Lana Keisha May 3, 2026 0

In 2024, OpenAI CEO Sam Altman famously predicted that a single entrepreneur, leveraging the transformative power of artificial intelligence, could…

Read More
Neuroscience & Brain Research

New Research Suggests Fish Oil Supplements May Impede Brain Recovery Following Repeated Traumatic Injuries

Rifan Muazin Apr 26, 2026 0

The Medical University of South Carolina (MUSC) has released a groundbreaking study that challenges the long-standing perception of fish oil…

Read More
Pharmaceutical R&D

Tavapadon Poised for Competitive Parkinson’s Disease Market Following Promising Tremor Data

Teuku Ryan Apr 24, 2026 0

AbbVie’s tavapadon, an investigational oral once-daily dopamine D1/D5 partial agonist, is nearing a potential regulatory submission, bolstered by new post-hoc…

Read More

Posts pagination

1 2
Indiana University Researchers Revolutionize Bone Marrow Analysis with Breakthrough Multiplex Imaging Technique for Mouse ModelsPharmSci 360 2026 heads to New Orleans this OctoberUniversity of California San Francisco Study Reveals Lungs as a Primary Site for Human Blood Production and Stem Cell ReservoirsTWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ